You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 12, December 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group


OBJECTIVE: To determine the roles of immediate pars plana vitrectomy (VIT) and systemic antibiotic treatment in the management of postoperative endophthalmitis. DESIGN: Investigator-initiated, multicenter, randomized clinical trial. SETTING: Private and university-based retina-vitreous practices. PATIENTS: A total of 420 patients who had clinical evidence of endophthalmitis within 6 weeks after cataract surgery or secondary intraocular lens implantation. INTERVENTIONS: Random assignment according to a 2 x 2 factorial design to treatment with VIT or vitreous tap or biopsy (TAP) and to treatment with or without systemic antibiotics (ceftazidime and amikacin). MAIN OUTCOME MEASURES: A 9-month evaluation of visual acuity assessed by an Early Treatment Diabetic Retinopathy Study acuity chart and media clarity assessed both clinically and photographically. RESULTS: There was no difference in final visual acuity or media clarity with or without the use of systemic antibiotics. In patients whose initial visual acuity was hand motions or better, there was no difference in visual outcome whether or not an immediate VIT was performed. However, in the subgroup of patients with initial light perception-only vision, VIT produced a threefold increase in the frequency of achieving 20/40 or better acuity (33% vs 11%), approximately a twofold chance of achieving 20/100 or better acuity (56% vs 30%), and a 50% decrease in the frequency of severe visual loss (20% vs 47%) over TAP. In this group of patients, the difference between VIT and TAP was statistically significant (P < .001, log rank test for cumulative visual acuity scores) over the entire range of vision. CONCLUSIONS: Omission of systemic antibiotic treatment can reduce toxic effects, costs, and length of hospital stay. Routine immediate VIT is not necessary in patients with better than light perception vision at presentation but is of substantial benefit for those who have light perception-only vision.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Endophthalmitis: Antibacterial Activity of Precipitates of Vancomycin and Ceftazidime
Chen et al.
J. Clin. Microbiol. 2008;46:2149-2149.
FULL TEXT  

Eubacterial PCR for Bacterial Detection and Identification in 100 Acute Postcataract Surgery Endophthalmitis
Chiquet et al.
IOVS 2008;49:1971-1978.
ABSTRACT | FULL TEXT  

{alpha}B-Crystallin Protects Retinal Tissue during Staphylococcus aureus- Induced Endophthalmitis
Whiston et al.
Infect. Immun. 2008;76:1781-1790.
ABSTRACT | FULL TEXT  

Treatment of Postcataract Extraction Endophthalmitis: A Summary of the Results From the Endophthalmitis Vitrectomy Study
Doft
Arch Ophthalmol 2008;126:554-556.
FULL TEXT  

Legacy of the Endophthalmitis Vitrectomy Study
Flynn and Scott
Arch Ophthalmol 2008;126:559-561.
FULL TEXT  

Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery
Murphy et al.
Br. J. Ophthalmol. 2007;91:1350-1353.
ABSTRACT | FULL TEXT  

Downregulation of Endotoxin-Induced Uveitis by Intravitreal Injection of Vasoactive Intestinal Peptide Encapsulated in Liposomes
Lajavardi et al.
IOVS 2007;48:3230-3238.
ABSTRACT | FULL TEXT  

The 100 Most Frequently Cited Articles in Ophthalmology Journals
Ohba et al.
Arch Ophthalmol 2007;125:952-960.
ABSTRACT | FULL TEXT  

Acute Postoperative Endophthalmitis Caused by Staphylococcus lugdunensis
Chiquet et al.
J. Clin. Microbiol. 2007;45:1673-1678.
ABSTRACT | FULL TEXT  

Prophylaxis of Acute Posttraumatic Bacterial Endophthalmitis: A Multicenter, Randomized Clinical Trial of Intraocular Antibiotic Injection, Report 2
Soheilian et al.
Arch Ophthalmol 2007;125:460-465.
ABSTRACT | FULL TEXT  

Endophthalmitis, a rare metastatic bacterial complication of haemodialysis catheter-related sepsis
Saleem et al.
Nephrol Dial Transplant 2007;22:939-941.
FULL TEXT  

Delivery from episcleral exoplants.
Pontes de Carvalho et al.
IOVS 2006;47:4532-4539.
ABSTRACT | FULL TEXT  

Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery.
Jensen and Fiscella
Am J Health Syst Pharm 2006;63:1637-1640.
FULL TEXT  

Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.
Gao et al.
IOVS 2006;47:1606-1611.
ABSTRACT | FULL TEXT  

Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
Hariprasad et al.
Arch Ophthalmol 2006;124:178-182.
ABSTRACT | FULL TEXT  

Clearance of Intravitreal Moxifloxacin
Iyer et al.
IOVS 2006;47:317-319.
ABSTRACT | FULL TEXT  

The pharmacokinetics of linezolid in the non-inflamed human eye
Prydal et al.
Br. J. Ophthalmol. 2005;89:1418-1419.
ABSTRACT | FULL TEXT  

Acute Endophthalmitis Incidence: Intravitreal Triamcinolone
Westfall et al.
Arch Ophthalmol 2005;123:1075-1077.
ABSTRACT | FULL TEXT  

Fas Ligand but Not Complement Is Critical for Control of Experimental Staphylococcus aureus Endophthalmitis
Engelbert and Gilmore
IOVS 2005;46:2479-2486.
ABSTRACT | FULL TEXT  

Penetration of moxifloxacin into the human aqueous humour after oral administration
Kampougeris et al.
Br. J. Ophthalmol. 2005;89:628-631.
ABSTRACT | FULL TEXT  

Changing Trends in the Microbiologic Aspects of Postcataract Endophthalmitis
Recchia et al.
Arch Ophthalmol 2005;123:341-346.
ABSTRACT | FULL TEXT  

An Unexpected Experimental Pitfall in the Molecular Diagnosis of Bacterial Endophthalmitis
Ugahary et al.
J. Clin. Microbiol. 2004;42:5403-5405.
ABSTRACT | FULL TEXT  

Intravitreally Injected Human Immunoglobulin Attenuates the Effects of Staphylococcus aureus Culture Supernatant in a Rabbit Model of Toxin-Mediated Endophthalmitis
Perkins et al.
Arch Ophthalmol 2004;122:1499-1506.
ABSTRACT | FULL TEXT  

An in vitro study on the compatibility and precipitation of a combination of ciprofloxacin and vancomycin in human vitreous
Hui et al.
Br. J. Ophthalmol. 2004;88:218-222.
ABSTRACT | FULL TEXT  

Risk factors of acute endophthalmitis after cataract extraction: a case-control study in Asian eyes
Wong and Chee
Br. J. Ophthalmol. 2004;88:29-31.
ABSTRACT | FULL TEXT  

Topical Antibiotics Before Cataract Surgery--Reply
Donnenfeld and Solomon
JAMA 2003;290:2938-2938.
FULL TEXT  

Gemella haemolysans acute postoperative endophthalmitis
Raman et al.
Br. J. Ophthalmol. 2003;87:1192-1193.
FULL TEXT  

Vitreous and Aqueous Penetration of Orally Administered Gatifloxacin in Humans
Hariprasad et al.
Arch Ophthalmol 2003;121:345-350.
ABSTRACT | FULL TEXT  

An In Vitro Study of Ceftazidime and Vancomycin Concentrations in Various Fluid Media: Implications for Use in Treating Endophthalmitis
Kwok et al.
IOVS 2002;43:1182-1188.
ABSTRACT | FULL TEXT  

Vitreous penetration of levofloxacin in the uninflamed phakic human eye
Herbert et al.
Br. J. Ophthalmol. 2002;86:387-389.
ABSTRACT | FULL TEXT  

Macular infarction after intravitreal amikacin: mounting evidence against amikacin
Galloway et al.
Br. J. Ophthalmol. 2002;86:359-360.
FULL TEXT  

Retinal Detachment and Culture-Proven Bacterial Endophthalmitis in the EVS
Enzenauer et al.
Arch Ophthalmol 2002;120:230-231.
FULL TEXT  

Diabetes and the EVS: A Different Interpretation of the Results
Enzenauer et al.
Arch Ophthalmol 2002;120:231-233.
FULL TEXT  

Bacterial Endophthalmitis: Epidemiology, Therapeutics, and Bacterium-Host Interactions
Callegan et al.
Clin. Microbiol. Rev. 2002;15:111-124.
ABSTRACT | FULL TEXT  

Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis
Gan et al.
Br. J. Ophthalmol. 2001;85:1289-1293.
ABSTRACT | FULL TEXT  

Diabetes and Postoperative Endophthalmitis in the Endophthalmitis Vitrectomy Study
Doft et al.
Arch Ophthalmol 2001;119:650-656.
ABSTRACT | FULL TEXT  

Management of Endophthalmitis in the Post-Endophthalmitis Vitrectomy Study Era
Sternberg and Martin
Arch Ophthalmol 2001;119:754-755.
FULL TEXT  

Does Endophthalmitis Following Strabismus Surgery Require Scleral Perforation?
Bloom et al.
Arch Ophthalmol 2001;119:783-785.
FULL TEXT  

Retinal Detachment in the Endophthalmitis Vitrectomy Study
Doft et al.
Arch Ophthalmol 2000;118:1661-1665.
ABSTRACT | FULL TEXT  

Risk factors for development of post-trabeculectomy endophthalmitis
Lehmann et al.
Br. J. Ophthalmol. 2000;84:1349-1353.
ABSTRACT | FULL TEXT  

Xanthomonas maltophilia Endophthalmitis After Cataract Surgery
Chaudhry et al.
Arch Ophthalmol 2000;118:572-575.
FULL TEXT  

Intraocular penetration of vancomycin eye drops after application to the medial canthus with closed lids
Alster et al.
Br. J. Ophthalmol. 2000;84:300-302.
ABSTRACT | FULL TEXT  

Amikacin retinal toxicity
JACKSON and WILLIAMSON
Br. J. Ophthalmol. 1999;83:1194f-1194.
FULL TEXT  

Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study
Das et al.
Br. J. Ophthalmol. 1999;83:1050-1055.
ABSTRACT | FULL TEXT  

Vancomycin Concentration in the Vitreous After Intravenous and Intravitreal Administration for Postoperative Endophthalmitis
Ferencz et al.
Arch Ophthalmol 1999;117:1023-1027.
ABSTRACT | FULL TEXT  

The CONSORT Statement: Will It Lead to Improved Reporting of Clinical Trials in Ophthalmology?
Hawkins
Arch Ophthalmol 1999;117:677-680.
FULL TEXT  

Posttraumatic Endophthalmitis
Meredith
Arch Ophthalmol 1999;117:520-521.
FULL TEXT  

Intraocular lens implants and risk of endophthalmitis
Bainbridge et al.
Br. J. Ophthalmol. 1998;82:1312-1315.
ABSTRACT | FULL TEXT  

Endogenous endophthalmitis resulting from sternal wound infection after coronary artery bypass grafting
Nahata et al.
J. Thorac. Cardiovasc. Surg. 1998;116:176-177.
FULL TEXT  

Postoperative Streptococcus pneumoniae Endophthalmitis Complicated by Meningitis
Chan et al.
Arch Ophthalmol 1998;116:951-953.
FULL TEXT  

Pharmacokinetics of Sparfloxacin in the Serum and Vitreous Humor of Rabbits: Physicochemical Properties That Regulate Penetration of Quinolone Antimicrobials
Liu et al.
Antimicrob. Agents Chemother. 1998;42:1417-1423.
ABSTRACT | FULL TEXT  

The treatment of endophthalmitis---still an exercise in frustration
WHITCHER
Br. J. Ophthalmol. 1997;81:713-714.
FULL TEXT  

Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis
Okhravi et al.
Br. J. Ophthalmol. 1997;81:719-725.
ABSTRACT | FULL TEXT  

Morganella morganii postoperative endophthalmitis
CUNNINGHAM et al.
Br. J. Ophthalmol. 1997;81:168c-168.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.